On Tuesday, 20 May 2025, Regeneron Pharmaceuticals (NASDAQ:REGN) presented at the RBC Capital Markets Global Healthcare Conference ... Factor XI Program: This initiative aims to develop a safer ...

Erik Wexler stepped into the top leadership role at 51-hospital Providence at a “tumultuous” time in healthcare, as he ...

Slovakia's COVID-19 vaccine sceptic prime minister said on Monday that his country would challenge the adoption of a ...

FusionLayer, a leading innovator in cloud infrastructure solutions, proudly announces its membership in the Open Programmable Infrastructure (OPI) Project, fostering an open ecosystem for ...

Bay Area News Group: Live Organ Donations Are Growing In The U.S., California And Bay Area, But So Is The Need Since 2014, more than 500,000 people in the U.S. have donated organs, 200,000 of ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

The partnership is poised to increase patient impact, especially for those who would benefit from enhanced care co-ordination ...